down arrow

Innova Captab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0DUT01020
  • NSEID: INNOVACAP
  • BSEID: 544067
INR
878.70
46.8 (5.63%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 39.86 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

830.00887.85

52 Week

421.551,259.00
Valuation
Technical
Day's Volume

CASH

39.86 k (-6.83%) Volume

Shareholding (Mar 2025)

FII

0.34%

Held by 15 FIIs

DII

19.76%

Held by 13 DIIs

Promoter

50.90%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.39 times

 
2

Healthy long term growth as Operating profit has grown by an annual rate 35.03%

 
3

The company has declared Positive results for the last 5 consecutive quarters

4

Technical trend is Sideways signifying no clear price momentum

5

With ROCE of 13.7, it has a Fair valuation with a 4.4 Enterprise value to Capital Employed

6

High Institutional Holdings at 20.11%

7

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 5,028 Cr (Small Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

13.22%

stock-summary
Price to Book

5.32

Revenue and Profits (1 Year):
Net Sales:
316 Cr
(Quarterly Results - Dec 2024)
Net Profit:
34 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
23.76%
0%
23.76%
1 Year
87.12%
0%
87.12%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Innova Captab for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
16.70%
EBIT Growth (5y)
35.03%
EBIT to Interest (avg)
64.74
Debt to EBITDA (avg)
2.62
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
0.99
Tax Ratio
25.60%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.11%
ROCE (avg)
12.76%
ROE (avg)
13.22%
Valuation key factors
Factor
Value
P/E Ratio
37
Industry P/E
33
Price to Book Value
5.32
EV to EBIT
31.64
EV to EBITDA
28.34
EV to Capital Employed
4.40
EV to Sales
4.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.74%
ROE (Latest)
13.22%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (10.75%)

FIIs

Held by 15 FIIs (0.34%)

Promoter with highest holding

Manoj Lohariwala (29.07%)

Highest Public shareholder

Gian Parkash Aggarwal (21.65%)

Individual Investors Holdings

27.62%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -0.55% vs 8.13% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -2.29% vs 18.72% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "316.46",
          "val2": "318.20",
          "chgp": "-0.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.56",
          "val2": "49.73",
          "chgp": "-6.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.17",
          "val2": "0.15",
          "chgp": "13.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34.20",
          "val2": "35.00",
          "chgp": "-2.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.71%",
          "val2": "15.63%",
          "chgp": "-0.92%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 18.65% vs 16.41% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 59.21% vs 30.14% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "612.47",
          "val2": "516.19",
          "chgp": "18.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "91.91",
          "val2": "71.78",
          "chgp": "28.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "13.84",
          "chgp": "-97.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "64.48",
          "val2": "40.50",
          "chgp": "59.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.01%",
          "val2": "13.91%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.47% vs 19.44% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 50.36% vs 29.45% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "928.93",
          "val2": "818.68",
          "chgp": "13.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "138.47",
          "val2": "116.38",
          "chgp": "18.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.46",
          "val2": "20.64",
          "chgp": "-97.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "98.68",
          "val2": "65.63",
          "chgp": "50.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.91%",
          "val2": "14.22%",
          "chgp": "0.69%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 0.73% vs 9.32% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 18.44% vs -13.04% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "864.93",
          "val2": "858.67",
          "chgp": "0.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "107.97",
          "val2": "98.53",
          "chgp": "9.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.59",
          "val2": "18.30",
          "chgp": "-25.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "68.16",
          "val2": "57.55",
          "chgp": "18.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.48%",
          "val2": "11.47%",
          "chgp": "1.01%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
316.46
318.20
-0.55%
Operating Profit (PBDIT) excl Other Income
46.56
49.73
-6.37%
Interest
0.17
0.15
13.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
34.20
35.00
-2.29%
Operating Profit Margin (Excl OI)
14.71%
15.63%
-0.92%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -0.55% vs 8.13% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -2.29% vs 18.72% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
612.47
516.19
18.65%
Operating Profit (PBDIT) excl Other Income
91.91
71.78
28.04%
Interest
0.29
13.84
-97.90%
Exceptional Items
0.00
0.00
Consolidate Net Profit
64.48
40.50
59.21%
Operating Profit Margin (Excl OI)
15.01%
13.91%
1.10%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 18.65% vs 16.41% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 59.21% vs 30.14% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
928.93
818.68
13.47%
Operating Profit (PBDIT) excl Other Income
138.47
116.38
18.98%
Interest
0.46
20.64
-97.77%
Exceptional Items
0.00
0.00
Consolidate Net Profit
98.68
65.63
50.36%
Operating Profit Margin (Excl OI)
14.91%
14.22%
0.69%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 13.47% vs 19.44% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 50.36% vs 29.45% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
864.93
858.67
0.73%
Operating Profit (PBDIT) excl Other Income
107.97
98.53
9.58%
Interest
13.59
18.30
-25.74%
Exceptional Items
0.00
0.00
Standalone Net Profit
68.16
57.55
18.44%
Operating Profit Margin (Excl OI)
12.48%
11.47%
1.01%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 0.73% vs 9.32% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 18.44% vs -13.04% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Innova Captab Ltd stock-summary
stock-summary
Innova Captab Ltd
Small Cap
Pharmaceuticals & Drugs
Innova Captab Limited was incorporated as `Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai. Thereafter, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."